A new tool, HPLC Studio, was developed for the comparison of high-performance liquid chromatography (HPLC) chromatograms from microbial extracts. The new utility makes it possible to create a virtual chromatogram by mixing up to 20 individual chromatograms. The virtual chromatogram is the first step in establishing a ranking of the microbial fermentation conditions based on either the area or diversity of HPLC peaks. The utility was used to maximize the diversity of secondary metabolites tested from a microorganism and therefore increase the chances of finding new lead compounds in a drug discovery program. (Journal of Biomolecular Screening 2003:305-315)
References
1.
1. Cragg GM, Newman DJ, Snader KM: Natural products in drug discovery and development . J Nat Prod1997;60: 52-60 .
2.
2. Harvey A: Strategies for discovering drugs from previously unexplored natural products . Drug Discov Today2000;5: 294-299 .
3.
3. Queener SW, Lively DH: Screening and selection for strain improvement. In Demain AL, Solomon NA (eds): Manual of Industrial Microbiology and Biotechnology. Washington, DC: American Society for Microbiology , 1986:155-169.
4.
4. Yarbrough GG, Taylor DP, Rowlands RT, Crawford MS, Lasure L: Screening microbial metabolites for new drugs: theoretical and practical issues . J Antibiot1993;46: 535-544 .
5.
5. Randall KJ: A method for quantitatively differentiating crude natural extracts using high-performance liquid chromatography-electrospray mass spectrometry . Anal Chem1998;70: 3249-3254 .
6.
6. Tormo JR, Garcia JB, De Antonio M, Mira A, Díez MT, Hernández P, et al: A method for selection of production media for actinomycete strains based on their secondary metabolite profiles . J Ind Microbiol Biotech; submitted for publication.
7.
7. Higgs RE, Zahn JA, Gygi JD, Hilton MD: Rapid method to estimate the presence of secondary metabolites in microbial extracts . App Environ Microbiol2000;67: 371-376 .
8.
8. Pichini S, Atieri I, Passa AR, Rosa M, Zuccaro P, Pacifici R: Use of solvent optimization for rapid selection of conditions for reversed-phase high-performance liquid chromatography of nicotine and its metabolites . J Chromatogr A1995;697: 383-388 .
9.
9. Bilke HW, Molnar I, Gernet CH: High-performance liquid chromatographic separation of the impurities in a pharmaceutical raw material with the aid of computer simulation . J Chromatogr A1996;729(1-2): 189-195 .
12. Vilella D, Sánchez M, Platas G, Salazar O, Genilloud O, Royo I, et al: Inhibitors of farnesylation of Ras from a natural products screening program . J Ind Microbiol Biotech2000;25: 315-327 .
13.
13. Wildmans H: Potential of tropical microfungi within the pharmaceutical industry. In Hyde KD (ed): Biodiversity of Tropical Microfungi. Hong Kong: Hong Kong University Press , 1997:29-46.
14.
14. Yarbrough GG, Taylor DP, Rowlands RT, Crawford MS, Lasure L: Screening microbial metabolites for new drugs: theoretical and practical issues . J Antibiot1993;46: 535-544 .
